All stock lists
TransUnion (TRU)
NYSE: TRU · Real-Time Price · USD
Financial Services · Financial Data & Stock Exchanges
78.06-3.42 (-4.20%)
Insider Score
––Not scored
TRU Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
TRU analyst forecast
TRU analyst consensus
Moderate Buy11 ratings
Buy 7 Hold 4 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
TRU 12-month price target
No published price targets in the last 12 months.
Best analysts covering TRU
- RBC Capital86%success rate · 7 calls
- Baird83%success rate · 6 calls
- Needham63%success rate · 8 calls
- Morgan Stanley50%success rate · 12 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
TRU analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | UBS | Neutral | — | — | Reiterated | 2026-10-21 |
| — | Mizuho | Neutral | — | — | Reiterated | 2026-10-19 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-10-16 |
| — | Needham | Buy | — | — | Reiterated | 2026-10-13 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-10-13 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-10-02 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2026-10-02 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2026-09-29 |
| — | UBS | Neutral | — | — | Reiterated | 2026-09-24 |
| — | UBS | Neutral | — | — | Reiterated | 2026-09-21 |
| — | Baird | Outperform | — | — | Reiterated | 2026-07-29 |
| — | Stifel | Buy | — | — | Reiterated | 2026-07-29 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-07-29 |
| — | BMO Capital | Outperform | — | — | Reiterated | 2026-07-29 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-07-29 |
| — | Needham | Buy | — | — | Reiterated | 2026-07-29 |
| — | Mizuho | Neutral | — | — | Reiterated | 2026-07-02 |
| — | UBS | Neutral | — | — | Reiterated | 2026-07-02 |
| — | UBS | Neutral | — | — | Reiterated | 2026-06-16 |
| — | B of A Securities | Neutral | — | — | Reiterated | 2026-05-19 |
| — | Needham | Buy | — | — | Reiterated | 2026-04-29 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-04-29 |
| — | UBS | Neutral | — | — | Reiterated | 2026-04-13 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-03-11 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2026-02-17 |
| — | Stifel | Buy | — | — | Reiterated | 2026-02-13 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-02-13 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-02-13 |
| — | Needham | Buy | — | — | Reiterated | 2026-02-13 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-01-14 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2025-12-17 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2025-10-24 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-10-24 |
| — | BMO Capital | Outperform | — | — | Reiterated | 2025-10-24 |
| — | Needham | Buy | — | — | Reiterated | 2025-10-24 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2025-10-02 |
| — | Needham | Buy | — | — | Upgraded | 2025-09-03 |
| — | UBS | Neutral | — | — | Reiterated | 2025-07-25 |
| — | BMO Capital | Outperform | — | — | Reiterated | 2025-07-25 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2025-07-25 |
| — | Needham | Hold | — | — | Reiterated | 2025-07-25 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2025-07-08 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2025-05-22 |
| — | Stifel | Buy | — | — | Reiterated | 2025-04-25 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2025-04-25 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2025-04-14 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2025-04-04 |
| — | Needham | Hold | — | — | Reiterated | 2025-02-14 |
| — | UBS | Neutral | — | — | Reiterated | 2025-02-03 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2025-01-28 |
| — | Needham | Hold | — | — | Reiterated | 2025-01-16 |
| — | Jefferies | Buy | — | — | Reiterated | 2025-01-15 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2025-01-10 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2025-01-07 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2024-12-12 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2024-11-20 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2024-10-24 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2024-10-24 |
| — | Stifel | Buy | — | — | Reiterated | 2024-10-24 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2024-10-24 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
